Exelixis (EXEL) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Exelixis (EXEL) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | -34.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -34.19% |
| Jan 2, 2026 | 326,071.19% |
| Oct 3, 2025 | 2,493.91% |
| Jul 4, 2025 | 659.17% |
| Apr 4, 2025 | 4,613.75% |
| Jan 3, 2025 | -75.10% |
| Sep 27, 2024 | 12,184.71% |
| Jun 28, 2024 | 884.30% |
| Mar 29, 2024 | 104.92% |
| Dec 29, 2023 | 1,324.42% |
| Sep 29, 2023 | -126.49% |
| Jun 30, 2023 | -42.72% |
| Mar 31, 2023 | -79.48% |
| Dec 30, 2022 | -123.19% |
| Sep 30, 2022 | -99.09% |
| Jul 1, 2022 | -98.91% |
| Apr 1, 2022 | 162.16% |
| Dec 31, 2021 | -49.18% |
| Oct 1, 2021 | 128.64% |
| Jul 2, 2021 | 34.37% |